Articles On IDT Australia (ASX:IDT)

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Hemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The legislation allows conditionally licensed cannabis farmers to grow weed, but they must meet certain requirements, including safe, sustainable a...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

The S&P/ASX200 climbed into the close on Tuesday. Most of the 35 or so point gain (0.5%)  comes off the back of some good, steady central banking, delivered – nay, telegraphed – at 2.30pm when the Reserve Bank (RBA) left the cash rate a...

As inflation sticks around and rate hikes come into play then volatility will pick up, the general consensus says. But volatility doesn’t mean a one way ticket into the red sea – it also means stocks can go back up after they slump. So it w...

In December France banned the sale of hemp flower and leaf loaded with CBD, but the Conseil d’Etat provisionally overruled the decision on Wednesday – pending further examination of the order. Basically, the French court said that flowers...

The ASX closed the second last trading day of the year – and the last full day of the year – slightly higher marking the sixth straight day of gains. This was despite a quiet day for trading and no sectors standing out with the best being t...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

The Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product sales estimated at $230 million. And medical cannabis prescriptions are at an all-time high. The TGA said 13,666 Australian patients were app...

Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength Index (RSI). The RSI is a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the le...

This week has been a good time to be a company helping in the front line fight against COVID-19 but the dreams of IDT (ASX:IDT) to be one of them appear to have been crushed yesterday. Since March the pharmaceutical manufacturer, which was...

While US markets rose after the Fed outlined plans to gradually withdraw stimulus, our markets did not follow suit even amidst a sea of deals. Leading the charge today was IGO (ASX:IGO) which after months of negotiations looks to have inked...

IDT Australia’s (IDT) submission for the Australian Government’s Approach To Market for an onshore mRNA manufacturing facility has been knocked back The Government announced a new manufacturing facility will be built in collaboration with...

The IDT Australia Limited (ASX: IDT) share price is crashing down to Earth on Thursday morning. At the time of writing, the pharmaceutical manufacturing company’s shares are down 37% to 30 cents. Why is the IDT Australia share price crashi...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

J-Pow and the gang are back on deck with a bang later tonight, and ASX investors appeared to buckle up in the safety seat ahead of the all-important Fed meeting. The ASX 200 finished around 0.7% lower, with a steeper fall of 1.4% in the mic...

Resources stocks Quantum Graphite (ASX:QGL) and Altura Mining (ASX:AJM) were reinstated after being suspended for several months and had contrasting fates. Quantum Graphite, which has the ‘Uley’ graphite prokect in South Australia, more tha...

The IDT Australia Limited (ASX: IDT) share price is on ice today after the company requested a trading halt. Before it was put on hold, the IDT share price was trading at 48 cents apiece. IDT is a Melbourne-based pharmaceutical company i...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Going into...

The IDT Australia Limited (ASX: IDT) share price has been up and down today, currently down 2.46% to 59.5 cents per share. Today’s price swings follow on from an outstanding performance yesterday. After the ASX medical research company rep...

The Starpharma Holdings Limited (ASX: SPL) share price is racing ahead this morning after confirming its antiviral nasal spray will be launched in Vietnam this week. The biotech registered its VIRALEZE spray for sale in the Asian country....

Highlights  The new COVID-19 variant Omicron is gradually approaching many counties around the world. This variant has numerous mutations and was first detected in South Africa. Countries are worried as the virus is highly infectious....

The ASX returned to positive territory today as investors began to shrug off fears of the omicron variant, but the bourse is still well below levels seen last week. While utilities lost over 1%, most other sectors gained with telcos being t...

The IDT Australia Limited (ASX: IDT) share price is entering the stratosphere today. This comes after the pharmaceutical manufacturing company announced a significant market update in regards to Australia’s mRNA manufacturing capability. A...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

Uber is expanding its horizons, with plans to allow users to order cannabis on its Uber Eats app. Next week the app will list cannabis retailer Tokyo Smoke on its marketplace and customers will be able to place orders on the app – but they...

Instead of a chocolate advent calendar this year, Californians can get their hands on a cannabis calendar with edibles, prerolls, grams of flower and four days of cannabis accessories. “We’ve seen the success of unique advent calendars in o...

Actor Jim Belushi has partnered with – you guessed it – Dan Aykroyd on a tour through Oklahoma’s cannabis industry ahead of a Blues Brothers performance. “We believe that cannabis is one of the great, great medicines that can lead to a path...

Last week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been slow...

IDT Australia (IDT) partners with the Monash University to produce a drug product for an mRNA COVID-19 receptor binding domain vaccine clinical trial This government-funded project aims to create Australia’s first locally manufactured cGMP...

Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr...

Once again the energy sector determined the direction of the market but unlike yesterday where it gained, today it finished in the red. The ASX 200 retreated 0.27% to close at 7,417 points, although the ASX Emerging Companies Index rose 1.3...

The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d...

The IDT Australia Limited (ASX: IDT) share price has slipped into the red during early trade on Tuesday. Despite this, IDT shares have been a major performer on the Australian broad indices lately. Whereas the S&P/ASX 200 Index (ASX:...

August was another month of lockdown for much of Australia’s East Coast but lockdowns and even a 2% drop in the middle of the month couldn’t stop the ASX from producing another winners list. The ASX 200 ultimately finished August 1.9% highe...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

Hot Money Monday is typically the domain of ASX small caps, but this week saw plenty of larger companies near the top end of the list as investors responded to some reporting season surprises. Each week, Stockhead recaps ASX stocks that are...

The ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday. The ASX Emerging Companies Index lost 0.57% to close at 2,285 points. The best sector was industrials which gained 1.07%. Tech and consume...

Virginia is the latest US state to legalise marijuana and they’re celebrating with the first annual CannaFest VA cannabis trade show on September 19. The event will feature a concert, and a custom car and motorcycle exhibition but no, you c...

Highlights  ASX-listed healthcare companies rarely fail to bring joy to the market participants, with a few of them providing outstanding returns in the last couple of months. Rhinomed, IDT Australia, and Prescient lead the way with ou...

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

The IDT Australia Limited (ASX: IDT) share price has soared into the green during early trade on Monday. IDT shares are on the move as the pharmaceuticals company gave a key update. Let’s investigate further. What did IDT announce? IDT...

IDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with the Australian Government to potentially assist with the production of a COVID-19 vaccine. There was recent media interest surrounding a mR...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Ikwezi Mining (ASX:IKW) topped the latest Running Hot list with a 14-day RSI of 82, after two straight weeks where lithium stocks dominated. Each week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength I...

Another red day for the ASX to close out the week. The ASX 200 closed 0.05% down from yesterday at 7,461 points, 2.2% lower than a week ago. The ASX Emerging Companies Index meanwhile dropped 2.09%, closing at 2,187 points which is over 5%...

While today was a better day for the ASX than the past two days, the bourse still finished slightly in the red After dropping by nearly 1% yesterday, the ASX 200 traded slightly higher for most of the day but closed 7,502 points, which was...